Summary of JAZZ PHARMACEUTICALS INC

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

JAZZ > SEC Filings for JAZZ > Form 8-K on 25-Jun-2009

All Recent SEC Filings

Show all filings for JAZZ PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for JAZZ PHARMACEUTICALS INC

25-Jun-2009

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events

On June 24, 2009, Jazz Pharmaceuticals, Inc. issued a joint press release with UCB announcing preliminary top-line results from the second of two Phase III pivotal clinical trials of JZP-6 (sodium oxybate) for the treatment of fibromyalgia. The full text of this press release is filed as Exhibit 99.1 to this Form 8-K and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Number Description
99.1 Press Release dated June 24, 2009

Add JAZZ to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for JAZZ - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.